Antimicrobial resistance (AMR) is one of the world’s most pressing and urgent global health threats— one that could erode the current progress against tuberculosis (TB), malaria, HIV/AIDS, and many other infectious diseases. In conjunction with World Antibiotic Awareness Week (14-20 November), the SIAPS Program has published a technical program update on Combating Antimicrobial Resistance with Stronger Health […]
Archive | AMRRSS feed for this section
Antimicrobial resistance (AMR) is one of the world’s most pressing and urgent global health threats— one that could erode the current progress against tuberculosis (TB), malaria, HIV/AIDS, and many other infectious diseases. AMR poses an enormous threat to the safety and feasibility of complex surgeries and procedures like organ transplantation and chemotherapy, but could also make childbirth, minor infections, and hospital stays more perilous. While AMR has emerged as a critical issue at the global level, current efforts to address AMR are insufficient to curb its spread. Immediate, cross-cutting, and multidisciplinary action is required to adequately address the multidimensional drivers of AMR. In the health sector, strengthening the systems through which health services and medicines are provided is a prerequisite to making progress against AMR.
This technical program update discusses how the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, funded by the US Agency for International Development (USAID), is working to address AMR through a health system strengthening approach with interventions spanning the global, regional, national, and local levels.
By Aubrey Clark, Technical Advisor for Pharmaceutical Services, and Mohan P. Joshi, Principal Technical Advisor and Cluster Lead for Pharmaceutical Services On September 21st, global leaders attending this year’s United Nations General Assembly will discuss one of the most pressing global public health threats of our time: antimicrobial resistance (AMR). This AMR meeting is only the […]
Improving Infection Prevention and Control Practices at Health Facilities in Resource-Limited Settings: SIAPS Technical Report
Infection prevention and control (IPC) is essential to reduce the spread of health facility-acquired (nosocomial) infections, including drug-resistant ones.
The USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program’s goal in global technical assistance in IPC is to reduce the development and spread of nosocomial infections and antimicrobial resistance. This contributes to an improved quality of patient care and safety in public health facilities in resource-constrained countries.
This report summarizes key accomplishments and lessons learned in implementing SIAPS’ approach to improving IPC practices in four countries: South Africa, Namibia, Jordan, and Ethiopia. All activities address SIAPS’s overall objective to build or enhance national and facility capacity to develop, implement, and monitor IPC programs by focusing on the principles of health systems strengthening.
Joshi MP. Containing antimicrobial resistance to realize the goals of universal health coverage. Oral presentation at the Ecumenical Pharmaceutical Network (EPN) Forum 2016, Tubingen, Germany. May 18-21, 2016.
Delegates at the Ecumenical Pharmaceutical Network (EPN) Forum 2016, agreed upon and issued a Call to Action against antimicrobial resistance during the biannual meeting, held 18-21 May 2016, in Tubingen, Germany. EPN, a partner of the USAID-funded SIAPS Program, issued the renewed call to action with support from SIAPS and other partners. The Call to […]
The EPN Forum 2016, held 18-21 May 2016, in Tubingen, Germany, convened EPN constituents and stakeholders to intensify the network’s focus on major challenges in the pharmaceutical sector, including antimicrobial resistance (AMR). The forum was a chance for stakeholders to exchange ideas, share knowledge and best practices, and chart an effective course of action to […]
This week, the global health and development community is commemorating the first World Antibiotic Awareness Week. Spearheaded by the World Health Organization (WHO) to raise global awareness on the magnitude, reach, and severity of antibiotic resistance; the event comes at a time when resistance to many antimicrobials, not just antibiotics, has now escalated to pandemic […]
The second in the series, the newly published, SIAPS-authored course on Antimicrobial Resistance expands upon the concepts presented in Part 1 and explains the major factors that contribute to the development and spread of antimicrobial resistance. The course also explores some of the proven interventions and global strategies currently being used to combat AMR, reviews […]
Briggs J, Joshi MP, Yeager B, Diarra S. Ensuring access to and appropriate use of medicines for iCCM: It takes a system. Oral presentation at the 143rd American Public Health Association (APHA) Annual Meeting and Expo, Chicago, IL, USA. November 3, 2015.